465 related articles for article (PubMed ID: 27575519)
21. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
[TBL] [Abstract][Full Text] [Related]
22. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
[TBL] [Abstract][Full Text] [Related]
23. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
Jo SH; Hong HK; Chong SH; Lee HS; Choe H
Pharmacol Res; 2009 Nov; 60(5):429-37. PubMed ID: 19497368
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of a bisbenzylisoquinline alkaloid dauricine on HERG potassium channels.
Zhao J; Lian Y; Lu C; Jing L; Yuan H; Peng S
J Ethnopharmacol; 2012 Jun; 141(2):685-91. PubMed ID: 21920426
[TBL] [Abstract][Full Text] [Related]
25. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
[TBL] [Abstract][Full Text] [Related]
26. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression.
Huo J; Zhang A; Guo X; Qiang H; Liu P; Bai L; Ma A
Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):851-61. PubMed ID: 27199074
[TBL] [Abstract][Full Text] [Related]
28. Discovery and electrophysiological characterization of SKF-32802: A novel hERG agonist found through a large-scale structural similarity search.
Donovan BT; Bandyopadhyay D; Duraiswami C; Nixon CJ; Townsend CY; Martens SF
Eur J Pharmacol; 2018 Jan; 818():306-327. PubMed ID: 29050968
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis.
Dong ZX; Zhao X; Gu DF; Shi YQ; Zhang J; Hu XX; Hu MQ; Yang BF; Li BX
Cell Physiol Biochem; 2012; 29(3-4):431-42. PubMed ID: 22508050
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.
Takemasa H; Nagatomo T; Abe H; Kawakami K; Igarashi T; Tsurugi T; Kabashima N; Tamura M; Okazaki M; Delisle BP; January CT; Otsuji Y
Br J Pharmacol; 2008 Feb; 153(3):439-47. PubMed ID: 17965736
[TBL] [Abstract][Full Text] [Related]
31. HERG K+ channel blockade by the novel antiviral drug sophocarpine.
Zhao XL; Qi ZP; Fang C; Chen MH; Lv YJ; Li BX; Yang BF
Biol Pharm Bull; 2008 Apr; 31(4):627-32. PubMed ID: 18379053
[TBL] [Abstract][Full Text] [Related]
32. Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels.
Chae YJ; Lee KJ; Lee HJ; Sung KW; Choi JS; Lee EH; Hahn SJ
Eur J Pharmacol; 2015 Apr; 752():1-7. PubMed ID: 25680947
[TBL] [Abstract][Full Text] [Related]
33. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
Rajamani S; Eckhardt LL; Valdivia CR; Klemens CA; Gillman BM; Anderson CL; Holzem KM; Delisle BP; Anson BD; Makielski JC; January CT
Br J Pharmacol; 2006 Nov; 149(5):481-9. PubMed ID: 16967046
[TBL] [Abstract][Full Text] [Related]
35. F463L increases the potential of dofetilide on human ether-a-go-go-related gene (hERG) channels.
Cheng G; Wu J; Han W; Sun C
Microsc Res Tech; 2018 Jun; 81(6):663-668. PubMed ID: 29573040
[TBL] [Abstract][Full Text] [Related]
36. Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration.
Kim YJ; Hong HK; Lee HS; Moh SH; Park JC; Jo SH; Choe H
J Cardiovasc Pharmacol; 2008 Dec; 52(6):485-93. PubMed ID: 19034039
[TBL] [Abstract][Full Text] [Related]
37. Clenbuterol Attenuates hERG Channel by Promoting the Mature Channel Degradation.
Luo L; Hu P; Miao C; Ma A; Wang T
Int J Toxicol; 2017; 36(4):314-324. PubMed ID: 28535735
[TBL] [Abstract][Full Text] [Related]
38. Blockage of hERG current and the disruption of trafficking as induced by roxithromycin.
Han SN; Yang SH; Zhang Y; Duan YY; Sun XY; Chen Q; Fan TL; Ye ZK; Huang CZ; Hu XJ; Zhang Z; Zhang LR
Can J Physiol Pharmacol; 2013 Dec; 91(12):1112-8. PubMed ID: 24289083
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.
Ridley JM; Milnes JT; Duncan RS; McPate MJ; James AF; Witchel HJ; Hancox JC
FEBS Lett; 2006 Apr; 580(8):1999-2005. PubMed ID: 16542653
[TBL] [Abstract][Full Text] [Related]
40. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
Gianulis EC; Trudeau MC
J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
